Search Results: immunotherapy

• Charity News
• For Supporters

Cancer Research UK partners with The Mark Foundation for Cancer Research to pave way for personalised immunotherapy treatments

The Mark Foundation for Cancer Research has partnered with Cancer Research UK to fund a new Cancer Grand Challenges team. The Mark Foundation for Cancer Research has partnered with Cancer Research UK to fund a new Cancer Grand Challenges team.

7 March 2024

• Science & Technology

The secret in cancer cells that can make immunotherapy more effective

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

31 January 2024

• For Supporters

Immunotherapy: puzzles and promise

Immunotherapy is a new type of treatment causing a buzz in the medical community. But what makes it so exciting? Immunotherapy is a new type of treatment causing a buzz in the medical community. But what makes it so exciting?

25 January 2024

• For Researchers

MOv18 - opening a new front for immunotherapy

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

12 December 2023

• Health & Medicine

Durvalumab immunotherapy recommended for advanced bile duct cancers in England and Scotland

The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland. The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland.

30 November 2023

• For Researchers

Government funding call brings team science to immunotherapy

Our very own Dr David Crosby tells us about a new consortium for cancer immunotherapy and how you could get involved…   Our very own Dr David Crosby tells us about a new consortium for cancer immunotherapy and how you could get involved…  

15 November 2023

• Health & Medicine

First immunotherapy approved for cervical cancer in England and Scotland

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

16 May 2023

• Science & Technology
• Health & Medicine

Repurposing radiotherapy drugs could give immunotherapy a boost

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

11 November 2022

• For Researchers

A new approach to cancer immunotherapy

Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials... Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials...

18 March 2022

• Health & Medicine

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England. Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

28 January 2022

• Health & Medicine

Immunotherapy approved for some people with advanced melanoma in England

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer. The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

21 December 2021

• Health & Medicine

Immunotherapy approved for some people with oesophageal cancer on NHS in England

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer. The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

20 October 2021